Table 4.
50–59 y. | 60–69 y. | 70–79 y. | 80–89 y. | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Women (n = 302) N (%) |
Men (n = 145) N (%) |
P value | Women (n = 343) N (%) |
Men (n = 131) N (%) |
P value | Women (n = 237) N (%) |
Men (n = 81) N (%) |
P value | Women (n = 92) N (%) |
Men (n = 28) N (%) |
P value | |
Cardiovascular disease (CVD)a | 12 (4.0) | 22 (15.2) | <0.001 | 22 (4.0) | 25 (19.1) | 0.004 | 38 (16.0) | 26 (32.1) | 0.002 | 20 (21.7) | 11 (39.3) | NS |
Venous thromboembolic events (VTE)b | 3 (1.0) | 1 (0.7) | NSc | 6 (1.7) | 1 (0.8) | NSc | 4 (1.7) | 3 (3.7) | NSc | 5 (5.4) | 0 (0.0) | NSc |
Hypertension (HT) | 31 (10.3) | 18 (12.4) | NS | 49 (14.3) | 16 (21.2) | NS | 40 (16.9) | 20 (24.7) | NS | 25 (27.2) | 3 (10.7) | NS |
Diabetes mellitus type 2 (DM2) | 11 (3.6) | 5 (3.4) | NS | 30 (8.7) | 12 (9.2) | NS | 18 (7.6) | 9 (11.1) | NS | 9 (9.8) | 2 (7.1) | NSc |
CVD or VTE | 14 (4.6) | 23 (15.9) | <0.001 | 36 (10.5) | 26 (19.8) | 0.007 | 39 (16.5) | 28 (34.6) | 0.001 | 23 (25.0) | 11 (39.3) | NS |
CVD or VTE or HT | 42 (13.9) | 39 (26.9) | 0.001 | 82 (23.9) | 38 (29.0) | NS | 67 (28.3) | 38 (46.9) | 0.002 | 42 (46.7) | 12 (42.9) | NS |
CVD or VTE or HT or DM2 | 50 (16.6) | 43 (29.7) | 0.001 | 99 (28.9) | 43 (32.8) | NS | 72 (30.4) | 42 (51.9) | 0.001 | 45 (48.9) | 13 (46.4) | NS |
aCardiovascular disease: having ischaemic heart disease or myocardial infarction or angina pectoris or percutaneous coronary intervention or bypass or cerebrovascular accident or transient ischaemic attack or peripheral artery disease in medical history.
bVenous thromboembolic events: having venous thromboembolism or pulmonary thromboembolism in medical history.
cFisher's exact test.